UK Biomanufacturing Team to Lead Development of Automated Controls
A UK-based consortium consisting of BiologIC Technologies, Biopharm Services, CPI, Pall Corporation, and SCIEX has announced the start of a
Read moreA UK-based consortium consisting of BiologIC Technologies, Biopharm Services, CPI, Pall Corporation, and SCIEX has announced the start of a
Read moreReal-world data has shown the Vaxzevria vaccine (formerly AZD1222), co-developed by AstraZeneca, the University of Oxford and its spin-out company,
Read moreMerck, also known as MSD, revealed that the U.S. Food and Drug Administration (FDA) has authorised VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate
Read moreThe University of Oxford has commenced a Phase I clinical trial of a novel HIV vaccine candidate with vaccinations underway
Read moreThe path for India’s first mRNA vaccine import has been cleared with Cipla winning approval to distribute Moderna’s COVID-19 vaccine.
Read morePharma giant Sanofi will spend €400 million annually towards a vaccines mRNA Center of Excellence, which will be the first
Read moreNucleai and Merck KGaA will collaborate utilizing Nucleai’s AI-powered platform to develop pathology-based biomarkers as companion diagnostics. Nucleai, a precision
Read moreInsilico Medicine, a Hong Kong-based pioneering biotechnology company, specialising in end-to-end artificial intelligence for target discovery, small molecule chemistry, and
Read moreThe legal dispute between the British-Swedish biopharmaceutical giant AstraZeneca and the European Union over a contract to deliver COVID-19 vaccines
Read moreThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of the Pfizer-BioNTech vaccine in children aged 12-15
Read more